HER2

A series of dice with a bag on them illustrating cost cuts
Biotech

Carisma axes sole clinical candidate, lays off 34% of staff

Carisma is implementing a 34% workforce reduction, which includes 23 staffers across R&D, manufacturing, finance and corporate activities.
Gabrielle Masson Dec 9, 2024 10:58am
Gut stomach

ESMO: Jazz HER2 bispecific posts 59% survival at 30 months

Sep 16, 2024 3:00am
Amazing landscapes of Appenzell with impressive rock formations and beautiful lakes

Boehringer, Bayer advance lung cancer meds toward Enhertu battle

Sep 9, 2024 4:43pm
downturn economy markets bank negative fall down

ALX's fizzling CD47 response rate sends stock spiraling down

Aug 1, 2024 5:34am
IPO initial public offering Wall Street

OS Therapies refiles $6M IPO to fund HER2 drug, preclinical ADCs

Aug 1, 2024 5:18am
pipeline leak pipe water tap

Zymeworks halts phase 2 ADC plans over 'clinical landscape'

Mar 7, 2024 9:00am